Bectas Therapeutics to Present at Biotech Showcase 2025
On January 15, 2025 Bectas Therapeutics will present an overview of their precision immunotherapy programs at The Biotech Showcase in San Francisco. This overview will include Bectas’ first-in-class antibody programs that focus on myeloid checkpoints in cancer and autoimmunity and that are enabled by patient selection biomarkers.